Prognostic Value of Circulating Cell-Free DNA Concentration and Neutrophil-to-Lymphocyte Ratio in Patients with Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25052854 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Bianca Varzaru und 13 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant PN-III-P1-1.2-PCCDI-2017-0797 (PANCNGS), PANCNGS.
Abstract (Originalsprache)
Circulating cell-free DNA (ccfDNA) quantity correlates with the clinical characteristics and prognosis of various cancer types. We investigated whether ccfDNA levels and the neutrophil-to-lymphocyte ratio (NLR) have prognostic value in patients with pancreatic ductal adenocarcinoma (PDAC). Peripheral blood was collected from 82 patients with PDAC prior to any diagnostic procedure or the administration of chemotherapy. Plasma DNA was isolated, and ccfDNA concentration and NLR were determined. We found that ccfDNA levels were correlated with age and tumor burden. Moreover, higher values of NLR (≥3.31) were linked with worse overall survival (OS) (4 vs. 10 months; log rank p = 0.011), and an elevated ccfDNA concentration (≥25.79 ng/mL) was strongly associated with shorter OS (4 vs. 8 months; log rank p = 0.009). According to the results of the multivariable Cox regression analysis, the baseline concentration of ccfDNA was an independent prognostic factor for OS (HR 0.45, 95% CI 0.21–0.97, p = 0.041). Furthermore, the combination of ccfDNA levels with NLR greatly enhanced the prognostic accuracy of PDAC patients. Our study demonstrates that ccfDNA concentration and NLR are independent predictors of survival in PDAC. Subsequent studies should validate this combination as a prognostic indicator in PDAC patients and assess its utility for guiding therapeutic decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Center of Excellence in Translational Medicine, Fundeni Clinical Institute, 022328 Bucharest, Romania.
- Digestive Diseases and Liver Transplantation Center, Fundeni Clinical Institute, 022238 Bucharest, Romania.
ORCID-Profile: Raluca Chelaru, Adina Croitoru, Simona Dima, Cristian Gheorghe
Förderung
- Grant PN-III-P1-1.2-PCCDI-2017-0797 (PANCNGS)
- PANCNGS
Zitieren
APA
Varzaru, B., Iacob, R. A., Bunduc, S., Manea, I., Sorop, A., Spiridon, A., Chelaru, R., Croitoru, A., Topala, M., Becheanu, G., Dumbrava, M., Dima, S., Popescu, I., & Gheorghe, C. (2024). Prognostic Value of Circulating Cell-Free DNA Concentration and Neutrophil-to-Lymphocyte Ratio in Patients with Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052854
Vancouver
Varzaru B, Iacob RA, Bunduc S, Manea I, Sorop A, Spiridon A, et al. Prognostic Value of Circulating Cell-Free DNA Concentration and Neutrophil-to-Lymphocyte Ratio in Patients with Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052854
BibTeX
@article{Varzaru2024,
author = {Varzaru, Bianca and Iacob, Razvan Andrei and Bunduc, Stefania and Manea, Ioana and Sorop, Andrei and Spiridon, Andreea and Chelaru, Raluca and Croitoru, Adina and Topala, Mihaela and Becheanu, Gabriel and Dumbrava, Mona and Dima, Simona and Popescu, Irinel and Gheorghe, Cristian},
title = {Prognostic Value of Circulating Cell-Free DNA Concentration and Neutrophil-to-Lymphocyte Ratio in Patients with Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25052854}
}
EUVIMED